. Author manuscript; available in PMC: 2023 May 1.

Published in final edited form as: J Obstet Gynaecol Res. 2022 Feb 9;48(5):1202–1211. doi: 10.1111/jog.15187

Table 1.

Measures of central tendency [median (min-max values)]

Variable (metric; normal values)	All patients (n=27)
Age (years)	32.04 (±11.95)^a
AMH (ng/mL; 0,07–7,35)	2.4 (0.1 – 8.5)^b
FGS (Ferriman Gallwey score)	10.13 (±7.83)^a
BMI (kg/m² ; 18,5–24,9)	28.44 (±7.38)^a
Waist / hip circumference (cm; <80)	86.5 (61 – 144)^b
Hip perimeter (cm; <105)	107.6 (±15.6)^a
Insulin (IU/mL; 1,9–23)	8.49 (1.77– 43.3)^b
Oral glucose tolerance test 75gr (mmol/L; <100 fasting blood sugar)	97 (60 – 168)^b
Oral glucose tolerance test 75gr_2 hours ((mmol/L; 2 hour<153)	84.22 (±14.52)^a
Dehydroepiandrosterone sulfate (μg/dL; 23–266)	173.96 (±8.83)^a
Sex hormone-binding globulin (nmol/L; 18–144)	37,31 (6.96 – 153)^b
Total Testesterone (ng/L; 0.15–0.7)	0.395 (0.071 – 1.09)^b
17-hydroxyprogesterone (ng/L; <8)	0.96 (0.42 – 2.815)^b
Androstenedione (ng/dL; 0,3–3,3)	4.26 (0.66 – 11.41)^b

“Mean” and “standard deviation” values in parentheses were specified for the data that fit the normal distribution.

“Median” and “lowest - highest values” in parentheses were specified for data that do not fit the normal distribution.